(3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid,-D3sodium salt; (3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl-d3)amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic Acid Monosodium Salt; [S-[R*,S*-(E)]]-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl-d3)amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic Acid Monosodium Salt; (3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-isopropyl-2-[(methanesulfonyl-d3)methylamino]pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic Acid Sodium Salt; Rosuvastatin-d3 Sodium
Rosuvastatin-d3 sodium salt is a fully characterized chemical compound used as a reference standard of API Rosuvastatin. The standard offered is compliant with regulatory guidelines. Rosuvastatin-d3 sodium salt is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1279031-70-7
Related products
Rosuvastatin EP Impurity C Calcium Salt
M.F.
M.W. 479.5 : 1/2(40.1)
CAT# AR-R09936
CAS# 1422514-05-3
Rosuvastatin EP Impurity B (Na Salt, Mix diastereomers)
M.F.
M.W. 481.5 : 23.0
CAT# AR-R10009
CAS# 1007871-86-4
Trial & Method Development - Separation of Rosuvastatin Impurity H Sodium Salt Diastereomers
M.F. -
M.W. -
CAT# AR-R00996
CAS# NA
Rosuvastatin Impurity H Sodium Salt (Mixture of Diastereomers)
M.F.
M.W. 960 22.99
CAT# AR-R00999
CAS# NA
Rosuvastatin (3S,5R) Enantiomer (Calcium salt)
M.F.
M.W. 2(481.5); 40.08
CAT# AR-R09961
CAS# 2414245-11-5
Rosuvastatin Impurity 6 Calcium Salt (6,7-Dihydro Rosuvastatin Calcium Salt)
M.F.
M.W. 482.55; 40.08
CAT# AR-R10051
CAS# NA
